Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Fate Therapeutics Inc Transaction History

Mitsubishi Ufj Kokusai Asset Management Co., Ltd.

$92.2 Billion
Q3 2024

A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 71,101 shares of FATE stock, worth $115,183. This represents 0.0% of its overall portfolio holdings.

Number of Shares

71,101

Previous 77,816 8.63%

Holding current value

$115,183

Previous $255,000 2.75%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$3.12 - $5.57 $20,950 - $37,402	-6,715 Reduced 8.63%	71,101 $248,000
Q2 2024 Aug 12, 2024	BUY	$3.26 - $7.08 $253,680 - $550,937	77,816 New	77,816 $255,000
Q3 2023 Nov 07, 2023	BUY	$2.02 - $5.04 $15,990 - $39,896	7,916 Added 15.11%	60,299 $127,000
Q2 2023 Aug 09, 2023	BUY	$4.76 - $6.59 $189,133 - $261,847	39,734 Added 314.13%	52,383 $249,000
Q4 2022 Feb 07, 2023	BUY	$9.86 - $23.83 $15,746 - $38,056	1,597 Added 14.45%	12,649 $127,000
Q3 2022 Nov 01, 2022	SELL	$21.04 - $36.06 $399 - $685	-19 Reduced 0.17%	11,052 $248,000
Q2 2022 Aug 04, 2022	BUY	$17.78 - $42.39 $97,985 - $233,611	5,511 Added 99.12%	11,071 $274,000
Q1 2022 May 09, 2022	BUY	$29.67 - $60.28 $9,791 - $19,892	330 Added 6.31%	5,560 $216,000
Q4 2021 Feb 07, 2022	BUY	$47.84 - $64.34 $53,532 - $71,996	1,119 Added 27.22%	5,230 $315,000
Q2 2021 Aug 06, 2021	SELL	$67.25 - $92.52 $204,910 - $281,908	-3,047 Reduced 42.57%	4,111 $357,000
Q1 2021 May 06, 2021	BUY	$72.16 - $117.4 $167,772 - $272,955	2,325 Added 48.11%	7,158 $590,000
Q4 2020 Feb 09, 2021	SELL	$38.09 - $100.95 $70,199 - $186,050	-1,843 Reduced 27.61%	4,833 $439,000
Q3 2020 Nov 10, 2020	SELL	$30.41 - $40.5 $1,277 - $1,701	-42 Reduced 0.63%	6,676 $267,000
Q2 2020 Aug 06, 2020	SELL	$20.21 - $35.23 $111,902 - $195,068	-5,537 Reduced 45.18%	6,718 $230,000
Q1 2020 May 11, 2020	BUY	$17.28 - $31.88 $42,854 - $79,062	2,480 Added 25.37%	12,255 $272,000
Q4 2019 Feb 05, 2020	BUY	$13.39 - $20.73 $26,177 - $40,527	1,955 Added 25.0%	9,775 $187,000
Q3 2019 Nov 12, 2019	BUY	$15.47 - $22.5 $23,653 - $34,402	1,529 Added 24.3%	7,820 $121,000
Q2 2019 Aug 08, 2019	SELL	$15.61 - $20.44 $98,858 - $129,446	-6,333 Reduced 50.17%	6,291 $128,000
Q1 2019 Apr 26, 2019	BUY	$13.15 - $18.71 $14,977 - $21,310	1,139 Added 9.92%	12,624 $222,000
Q4 2018 Feb 08, 2019	SELL	$11.48 - $16.98 $35,771 - $52,909	-3,116 Reduced 21.34%	11,485 $151,000
Q3 2018 Nov 13, 2018	BUY	$8.75 - $16.29 $127,758 - $237,850	14,601 New	14,601 $238,000

Others Institutions Holding FATE

# of Institutions

175

Shares Held

115M

Call Options Held

53.7K

Put Options Held

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $157M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.

Account

Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Fate Therapeutics Inc Transaction History